INNOVATIVE THERAPIES GROUP, INC.
LADY LAKE, FLORIDA

Innovative Therapies Group, Inc., incorporated in Florida on October 22, 2008, is a company with its mailing address located at PO Box 75, EastLake Weir, FL, 32133. It operates under the company type designation of DOMP and holds a status governed by Florida's business regulatory framework as denoted by Florida.Models.Dos.FloridaCompanyStatus. Innovative Therapies Group, Inc., is situated in Lady Lake, within the county of Lake, and its operations are registered with the state of Florida under Filed Number P08000096289. As a registered entity, it complies with all local business registration requirements as evidenced by its latest annual report submitted on February 4, 2024. The company maintains transparency in its communication channels through two contact numbers: (352) 433-0091 and (352) 433-0676. Additionally, further details about the organization's services and initiatives can be accessed via their website at innovativetherapiesgroup.com. Kimberly A Lancaster serves as an officer of the corporation under the title of Principal Shareholder Trustee (PST). The company holds a Federal Employer Identification Number (FEIN) of 263620015, which identifies it for business tax purposes.

KEY FACTS ABOUT INNOVATIVE THERAPIES GROUP, INC.

Company name
INNOVATIVE THERAPIES GROUP, INC.
Status
Active
Filed Number
P08000096289
FEI Number
263620015
Date of Incorporation
October 22, 2008
Age - 17 years
Home State
FL
Company Type
Domestic for Profit

CONTACTS

Website
http://innovativetherapiesgroup.com
Phones
(352) 433-0091
(352) 433-0676

INNOVATIVE THERAPIES GROUP, INC. NEAR ME

Principal Address
929 N HWY 27/441,
LADY LAKE,
FL,
32159,
US
Mailing Address
929 N HWY 27/441,
Lady Lake,
FL,
32159,
US

See Also

Officers and Directors

The INNOVATIVE THERAPIES GROUP, INC. managed by the one person from EASTLAKE WEIR on following positions: PST

Kimberly A Lancaster

Position
PST Active
From
EASTLAKE WEIR, FL





Registered Agent is Deborah L Kacera

From
EASTLAKE WEIR, 32133

Annual Reports

2025
January 17, 2025
2024
February 4, 2024